Skip to content


Inspra (eplerenone) is a small molecule pharmaceutical. Eplerenone was first approved as Inspra on 2002-09-27. It is used to treat hypertension and systolic heart failure in the USA. The pharmaceutical is active against mineralocorticoid receptor.
Trade Name Inspra
Common Name Eplerenone
Indication hypertension, systolic heart failure
Drug Class Aldosterone antagonists (spironolactone type)
Get full access now